StockNow
Calendar
Log in
Other

Genmab (GMAB DC/GMAB) 9M 2026 (USD): EBIT 986mln; Operating expenses 2.02bln; Darzalex sales 12.4bln

ORIGINAL · NewsquawkGenmab (GMAB DC/GMAB) 9M 2026 (USD): EBIT 986mln; Operating expenses 2.02bln; Darzalex sales 12.4bln
StockNow breaking-news AI analysis

The headline reports Genmab’s 9M 2026 EBIT, operating expenses, and Darzalex sales in USD; no supporting article text or further context was supplied.

1 stocks
GMABGenmab A/S ADS$54.21Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

Senior US officials see a high probability of war with Iran, N12 TV reports

Geopolitics

Pakistan's Deputy PM and Foreign Minister met Iran's ambassador and held separate calls with his Saudi and Omani counterparts over the past 24 hours to discuss regional de-escalation, Pakistani journalist Mallick reports

Fed

Fed's Hammack (hawkish dissenter) says gradual rate hikes less disruptive to economy and financial system and monetary policy needs to move to restrictive stance